Outsourced Pharma App Notes & Case Studies

1. Handling Demanding Active Ingredients Safely And Efficiently 1/27/2026

   See three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

2. Improving Efficiency In Contamination Identification 7/11/2025

   Discover how rapid microbial identification using MALDI-TOF improves contamination response, shortens investigation timelines, and enhances efficiency in biopharmaceutical manufacturing.

3. Progressing A Cystic Fibrosis Treatment With A Strong Culture Match 9/4/2025

   Collaborate with an experienced CMO that combines transparency, expertise, and a shared commitment to help advance complex biologics from preclinical research to clinical success.

4. Focus On Your Core Business Strategy 7/10/2025

   Learn how a large manufacturing client helped to focus on their core business with a solution that transitioned approximately 60% of the workforce and capitalized on the initial training investment.

5. Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology 3/12/2025

   Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.

6. AOC Conjugation – mAb With SiRNA 12/5/2025

   See how to overcome risks in mAb-SiRNA conjugation, including disulfide scrambling and SiRNA deconjugation, by using advanced chemical and operational solutions to improve material yield and stability.

7. Case Study: ThioBridge™ Conjugates 4/14/2025

   Discover how Abzena’s ThioBridge™ technology is enabling the next generation of stable, scalable, and clinically advanced ADCs through site-specific conjugation.

8. Exosome Isolation By TFF And Size Exclusion Chromatography 3/6/2024

   Here, we demonstrate a scalable workflow for the isolation of exosomes that combines tangential flow filtration for the concentration of exosomes followed by gentle size exclusion chromatography.

9. Virus Retention Performance Under Diverse Processing Conditions 11/14/2025

   Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.

10. Simplifying Antibody-Drug Conjugate Payload Synthesis 8/5/2025

    ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.